Ultralife Corporation ULBI
Set alert
15.62 USD 0.00 0.00%
At close · Nov 2
15.61 -0.01 -0.06%
After hours · Nov 2, 4:00 PM ET
15.61 Day range 15.64
4.90 52-week range 15.67
- YTD
- +173.08%
- 1 year
- +122.19%
- Open
- 15.62
- Prev close
- 15.62
- Mkt cap
- 260.30M
- Vol
- 248.34K
- Avg vol
- 98.60K
- EPS
- -0.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.61
- High
- 15.64
- Forward P/E
- 8.01
- Beta
- 0.98
- Short ratio
- 2.05
- Inst. own
- 74.12%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.15
- 200-d avg
- 9.75
- 1y target
- 14.00
Analyst view
Consensus: none
Price target (mean) 14.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.15 | 0.15 – 0.15 | 0.18 | -16.7% | 40.00M | -10.2% | 1 |
| Next quarter | 0.15 | 0.15 – 0.15 | 0.21 | -28.6% | 48.00M | +14.5% | 1 |
| Current year | 0.57 | 0.57 – 0.57 | 0.52 | +9.6% | 160.60M | +1.2% | 1 |
| Next year | 0.92 | 0.92 – 0.92 | 0.57 | +61.4% | 218.50M | +36.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jun 27, 2024 | Benchmark | Maintained | Buy | Buy |
| Mar 5, 2024 | Benchmark | Maintained | Buy | Buy |
| Aug 8, 2023 | Benchmark | Reiterated | Buy | Buy |
| Mar 26, 2021 | Benchmark | Initiated | — | Buy |
| May 2, 2013 | Ardour Capital | Downgrade | Hold | Reduce |